Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Premalignant Conditions
- PMID: 38596548
- PMCID: PMC11000854
- DOI: 10.55729/2000-9666.1252
Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Premalignant Conditions
Abstract
This review article aims to provide a comprehensive overview of recent epidemiology, pathogenesis, risk factors, and premalignant conditions of gastric cancer. Worldwide, gastric cancer is one of the most common and most fatal cancers. The incidence and mortality remain high in regions such as East Asia and Eastern Europe. Although there is a lower incidence in the United States, it remains a deadly disease. Age, gender, and race are non-modifiable demographic risk factors for developing gastric cancer. There have been several dietary and lifestyle risk factors such as salt preserved foods, N-nitroso compounds containing foods, tobacco smoke, alcohol use, and obesity that have been shown to contribute to the development of gastric cancer. Infections have additionally been shown to have a clear role in the pathogenesis of gastric cancer as Helicobacter pylori eradication has shown a significant reduction in the incidence of gastric cancer as well as other pathogens such as Epstein-Barr virus. There are certain premalignant lesions that increase the risk of developing gastric cancer. These include atrophic gastritis, and intestinal metaplasia amongst others.
Keywords: Atrophic gastritis; Gastric cancer demographics; Gastric cancer epidemiology; Gastric cancer etiology; Gastric cancer risk factors; Helicobacter pylori; Hereditary diffuse gastric cancer; Intestinal metaplasia; Ménétrier’s disease; N-nitroso compounds.
© 2023 Greater Baltimore Medical Center.
Conflict of interest statement
Conflicts of interest: The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article.
Similar articles
-
Premalignant lesions in gastric cancer.Clin J Gastroenterol. 2010 Feb;3(1):6-12. doi: 10.1007/s12328-009-0130-8. Epub 2009 Dec 16. Clin J Gastroenterol. 2010. PMID: 26189899
-
Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.Eur J Gastroenterol Hepatol. 2020 Jun;32(6):686-694. doi: 10.1097/MEG.0000000000001740. Eur J Gastroenterol Hepatol. 2020. PMID: 32355093
-
Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time.Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S79-83. Eur J Gastroenterol Hepatol. 1994. PMID: 7735941 Review.
-
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.Gastroenterology. 2021 Oct;161(4):1325-1332.e7. doi: 10.1053/j.gastro.2021.06.078. Epub 2021 Aug 26. Gastroenterology. 2021. PMID: 34454714 Free PMC article. Review.
-
Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.Helicobacter. 2007 Nov;12 Suppl 2:22-31. doi: 10.1111/j.1523-5378.2007.00562.x. Helicobacter. 2007. PMID: 17991173 Review.
Cited by
-
Current Understanding of Optimal Prevention of Helicobacter pylori-Induced Cancer.Gastroenterol Clin North Am. 2025 Jun;54(2):397-413. doi: 10.1016/j.gtc.2024.12.005. Epub 2025 Jan 24. Gastroenterol Clin North Am. 2025. PMID: 40348495 Free PMC article. Review.
-
Prognostic Significance of DNAJB4 Expression in Gastric Cancer: Correlation with CD31, Caspase-3, and Tumor Progression.Diagnostics (Basel). 2025 Mar 7;15(6):652. doi: 10.3390/diagnostics15060652. Diagnostics (Basel). 2025. PMID: 40149995 Free PMC article.
-
A New Model Based on Folate Receptor-Positive Circulating Tumor Cells for the Preoperative Prediction of Peritoneal Metastasis in Gastrointestinal Malignancies: A Retrospective Study in China.Gut Liver. 2025 Jul 15;19(4):536-547. doi: 10.5009/gnl240462. Epub 2025 Mar 5. Gut Liver. 2025. PMID: 40040290 Free PMC article.
-
Comprehensive analysis of lactylation-related gene sets and mitochondrial functions in gastric adenocarcinoma: implications for prognosis and therapeutic strategies.Front Immunol. 2024 Oct 16;15:1451725. doi: 10.3389/fimmu.2024.1451725. eCollection 2024. Front Immunol. 2024. PMID: 39478860 Free PMC article.
-
Helicobacter pylori Eradication Therapy and the Risk of Colorectal Cancer: A Population-Based Nationwide Cohort Study in Sweden.Helicobacter. 2024 Nov-Dec;29(6):e70001. doi: 10.1111/hel.70001. Helicobacter. 2024. PMID: 39567356 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313] CA Cancer J Clin. 2018 Jul;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
-
- International Agency for Research on Cancer. Stomach cancer fact sheet. [Accessed April 8, 2023]. https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf .
-
- National Cancer Institute. SEER cancer statistics review 1975–2017 stomach cancer. Bethesda, MD: National Cancer Institute; https://seer.cancer.gov/statfacts/html/stomach.html .
Publication types
LinkOut - more resources
Full Text Sources